Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Short term Debt (2016 - 2024)

Sanara MedTech's Short term Debt history spans 11 years, with the latest figure at $3.0 million for Q1 2024.

  • For Q1 2024, Short term Debt changed N/A year-over-year to $3.0 million; the TTM value through Mar 2024 reached $3.0 million, changed N/A, while the annual FY2023 figure was $580357.0, N/A changed from the prior year.
  • Short term Debt reached $3.0 million in Q1 2024 per SMTI's latest filing, up from $580357.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $3.0 million in Q1 2024 to a low of $114975.0 in Q3 2020.
  • Average Short term Debt over 3 years is $823581.6, with a median of $232143.0 recorded in 2023.
  • The largest YoY upside for Short term Debt was 80.96% in 2020 against a maximum downside of 94.25% in 2020.
  • A 3-year view of Short term Debt shows it stood at $114975.0 in 2020, then skyrocketed by 404.77% to $580357.0 in 2023, then skyrocketed by 416.92% to $3.0 million in 2024.
  • Per Business Quant, the three most recent readings for SMTI's Short term Debt are $3.0 million (Q1 2024), $580357.0 (Q4 2023), and $232143.0 (Q3 2023).